I became aware of this through "Endocrinology Advisor": pubmed.ncbi.nlm.nih.gov/381... The link to the paper was not given. I found it myself.
"Conclusions: Six months of combination therapy with twice-daily LT3 dose adapted according to TSH-level do not significantly change peripheral tissue response or quality of life, despite an increase in the fT3/fT4 ratio." This is from the paper.
"No between-group differences were observed in quality of life at the end of treatment. Only 11% of combination therapy participants preferred the combination therapy, whereas 56% of combination therapy patients and 60% of placebo patients considered the combination therapy to be more complicated than monotherapy.
Study limitations include reduction of clinical activity and subsequent dropouts due to the COVID-19 pandemic.
This study shows that patients treated with customized twice-daily doses of [liothyronine] in combination with [levothyroxine] have a significant reduction of TSH together with an increase of FT3 and FT3/FT4 compared to placebo,” according to the researchers. “However, no significant differences occur between groups in peripheral tissue markers of thyroid function, [quality of life], and BMI.” This is from Endocrinology Advisor.
Where did they get the percentages for dissatisfaction? Am I missing something?
It seems to me that the dose adjustments might have been made based on TSH. Also 6 months seems rather short for this kind of research. There might not have been a full benefit yet especially with doses still being adjusted. Could that account for patients (feeling no benefit) to find combination therapy too complicated? And where does it mention that specific reason in the research paper? Does EA maybe have additional information not mentioned in the paper? Or are they just making it easier for endos to use that as an argument to deny patients the combination treatment? Because endos will not likely seek out the research paper and just happily take EA's word for it.
Correct me if I went astray somewhere. I'm a bit miffed right now (and worried), which may have caused me to overlook something important.